NewsRoom Articles - Page 155 of 202

ThursdayApr 08, 2021 2:24 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Commercialization Team Set to Launch Rapid POC COVID Test Solution

Bioscience technology accelerator XPhyto Therapeutics Corp. is working with development partner 3a-diagnostics GmbH to roll out its pandemic-related virus diagnostic tool for the European market planned in April The test solution, dubbed “Covid-ID Lab,” received European regulatory approval last month XPhyto’s product is designed to be portable and rapid in its response time to help decrease testing operation costs and increase convenience of use News reports about the COVID-19 pandemic reflect a growing optimism that vaccine, mask and distancing protocols may be helping to drive down infection rates, although the reports note the virus continues to have a deadly effect…

ThursdayApr 08, 2021 1:08 pm

Brain Scientific Inc. (BRSF) Meeting the Needs of Neuro Research

BRSF is creating mobile, easy-to-use electroencephalogram (“EEG”) devices that enhance research integrity There is an increasing desire to understand the brain’s capabilities and harness them for healing Brain Scientific provides a cost-efficient, pre-gelled, disposable and wireless solution that provides the same signal quality as the traditional wired EEG A growing consumer market for brain-computer interface (“BCI”) technology has some researchers worried about the quality of the data being collected. Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, has developed wireless, portable, easy-to-use electroencephalogram (“EEG”) devices that do not compromise research integrity. Data collected from consumer-centric, low-cost BCIs…

WednesdayApr 07, 2021 2:43 pm

Patients with Incurable Brain Cancers Find New Hope in University Study, Upcoming CNS Pharmaceuticals (NASDAQ: CNSP) Clinical Trial

Glioblastoma Multiforme (often known simply as GBM) is a fatal, incurable class of brain cancers that usually leaves patients only about 15 months to live once they are diagnosed A recent study by the Washington University School of Medicine found that the length of survivability appeared to improve when the standard chemotherapy regimen was given in the morning instead of the evening Brain cancer drug developer CNS Pharmaceuticals is also working on a solution to improve the quality of GBM care, seeing hope in its lead drug candidate, Berubicin, which showed promise in a small Phase 1 trial nearly 15…

WednesdayApr 07, 2021 12:00 pm

Researchers Find Evidence Suggesting That Coronavirus Can Cause Type 2 Diabetes

A group of scientists from Monash University and King’s College London has developed a database of information that may help researchers find the link between type 2 diabetes and the coronavirus. The group designed the database for the following reasons: first, the increasing evidence that suggests that the coronavirus can actually cause individuals to become diabetic, and second, when compared to the general population, individuals who have type 2 diabetes are more likely to experience serious coronavirus symptoms and to die from the disease. Type 2 diabetes is a chronic condition that impacts the way the body processes blood sugar.…

WednesdayApr 07, 2021 11:55 am

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Innovative Imaging Technology Overcoming Challenges Involving Bladder Cancer Visualization

90% of the cystoscopies performed on bladder cancer patients use white light, which cannot always detect cancer margins or tumors that lie flat against the bladder wall. The American Urology Association recommends blue light for cystoscopic procedures involving bladder cancer. Imagin Medical’s i/Blue Imaging System(TM) provides the simultaneous, side-by-side display of white light and blue light images, making it easier to visualize cancer margins and flat tumors, potentially resulting in lower recurrence rates The company is has transitioned to the manufacturing stage of the i/Blue System with their contract manufacturer, Lighthouse Imaging Bladder cancer is the sixth most prevalent cancer…

TuesdayApr 06, 2021 1:01 pm

Healthy Extracts Inc.’s (HYEX) “Live Life Young Again” Strategy Reflects The Company’s Continued Optimism For 2021

Healthy Extracts Inc. recently declared its 2020 Q4 results, with revenue growth at 71% over the previous year The company’s 2021 strategy “Live Life Young Again” aligns with its plant-based product range and its overall confidence for 2021 Results of the clinical studies of the Fuel4Thought Brain Booster product were published in the renowned World Journal of Advanced Research and Reviews Healthy Extracts (OTCQB: HYEX), is engaged in the research, development, and sale of natural plant-based products that concentrate on nerve and heart health. The company’s growth and expansion are evident in the company’s robust 2020 Q4 results. Their latest financial…

TuesdayApr 06, 2021 12:30 pm

Researchers Create Lab-Made Heart Valves That Grow with Patient

A recent study led by researchers from the University of Minnesota, both from the College of Science and Engineering and the Medical School, demonstrated how heart valves that were developed in the lab and infixed in young lambs for a year could grow in the recipient. When tested in the same lamb model, the researchers found that the valves demonstrated decreased calcification and better flow of blood function in comparison with valves derived from animals. If those results are confirmed in humans, these heart valves may help prevent multiple valve replacement surgeries for children born annually with heart defects. Additionally,…

MondayApr 05, 2021 3:05 pm

Brain Scientific Inc. (BRSF) Provides Affordable Solutions for COVID Studies

Researchers struggle to understand the immediate effects of COVID, with no clear census on the long-term neurological impact COVID-19 has shown itself to be unique in how it interacts with the brain Brain e-tattoos implanted in forehead will be next wave of innovation for neurology Brain Scientific (OTCQB: BRSF) is meeting the growing need for improved brain monitoring with cost-efficient, disposable, and portable cutting-edge technology. This last year has seen an increased demand for disposable neurological technology accessible to all, adaptable for widespread use, and that provides quick, reliable information on the patient’s condition. As the pandemic winds down, thanks…

MondayApr 05, 2021 2:32 pm

United Medical Equipment Showcases Recent Rapid-Testing Research, Committed to Playing Key Role in COVID-19 Screening

Rapid testing is cheaper, faster than PCR testing; some fear test sensitivity is too low Recent studies show that test sensitivity is secondary to frequency and turnaround time for effective COVID-19 screening UME widespread rapid testing gains momentum as safe, reliable and more cost-effective alternative As a trusted supplier of testing kits, United Medical Equipment ("UME") is eager to provide assistance and support in the fight against COVID-19 as as research indicates effectiveness of rapid testing for COVID-19 screening (https://ibn.fm/eZoVI). Governments have invested significant resources in scaling up testing capacity as a response to the pandemic outbreak. Because SARS-CoV-2 can…

MondayApr 05, 2021 2:30 pm

Analysts Forecast That Smoking May Become Extinct in a Generation

According to analysts from Jefferies, two decades from now, there may be no smokers in the market. Tobacco firms and governments happen to be on the same side in this shift, especially now that more countries are adopting smoke-free targets and companies are advocating for smokers to use alternative products such as oral nicotine and vaping. In a note, one of the analysts, Owen Bennett, stated that as tobacco ambitions and regulators align, no smokers in a generation may become a reality, adding that the only way to achieve this would be through RRP support. Analysts aren’t the only ones…